+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?



Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?



Annals of Oncology 16(7): 1210-1211




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050163972

Download citation: RISBibTeXText

PMID: 15857845

DOI: 10.1093/annonc/mdi204


Related references

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). Annals of Oncology 18(7): 1159-1164, 2007

Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia. Gynecology and Minimally Invasive Therapy 7(1): 44-45, 2018

Amifostine in the prevention of liposomal doxorubicin induced palmar-plantar erythrodysesthesia. Blood 98(11 Part 2): 309b, November 16, 2001

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer ChemoTherapy and Pharmacology 44(4): 303-306, 1999

The use of cod liver oil by patients receiving pegylated liposomal doxorubicin is associated with a lack of severe palmar-plantar erythrodysesthesia. European Journal of Gynaecological Oncology 30(4): 387-388, 2009

Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin. Tumori 95(6): 687-690, 2010

Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer. Gynecologic Oncology 114(2): 219-224, 2009

Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08). Breast 23(3): 244-249, 2015

Fluorouracil and the palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine 102(3): 419, 1985

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine 101(6): 798-799, 1984

Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine 111(8): 688-689, 1989

Pyridoxine as prophylactic therapy for palmar-plantar erythrodysesthesia associated with administration of pegylated liposomal doxorubicin (caelyx): a single-center experience. Oncology 73(3-4): 277-278, 2008

Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients. Gynecologic Oncology 131(3): 683-688, 2014

Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin. Gynecologic Oncology 103(1): 72-74, 2006

Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. Pharmacotherapy 20(10): 1221-1223, 2000